HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges-Reference-Cited by-同舟云学术

HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges

Published:2006-08 Issue:1 Volume:352 Page:216-225
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Ellenberger Dennis,Otten Ronald A.,Li Bin,Aidoo Michael,Rodriguez I. Vanessa,Sariol Carlos A.,Martinez Melween,Monsour Michael,Wyatt Linda,Hudgens Michael G.,Kraiselburd Edmundo,Moss Bernard,Robinson Harriet,Folks Thomas,Butera Salvatore

Publisher

Elsevier BV

Subject

Virology

Reference50 articles.

1. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen;Allen;J. Immunol.,2000

2. Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication;Allen;J. Virol.,2002

3. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine;Amara;Science,2001

4. Critical role for Env as well as Gag–Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine;Amara;J. Virol.,2002

5. Cytokine-induced augmentation of DNA vaccine-elicited SIV-specific immunity in rhesus monkeys;Barouch;Dev. Biol.,2000

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent SIV-Macaque Trials: A Reassessment of Immune Priming and Varying Infectability in Repeated Low-dose Challenge Studies;2021-07-29

2. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus;Science;2021-02-26

3. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus;2020-09-10

4. Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models;Expert Review of Vaccines;2017-09-04

5. A method to address between-subject heterogeneity for identification of principal surrogate markers in repeated low-dose challenge HIV vaccine studies;Statistics in Medicine;2017-07-31